Historique
Document multimédia
Dual disorders: health and social responses
Auteur(s) :
EUDA (European Union Drugs Agency)
Année
2026
Langue(s) :
Anglais
Éditeur(s) :
Lisbon : European Union Drugs Agency (EUDA)
Collection :
Miniguide
Domaine :
Autres substances ; Drogues illicites
Discipline :
PSY (Psychopathologie / Psychopathology)
Thésaurus géographique
EUROPE
;
UNION EUROPEENNE
Thésaurus mots-clés
COMORBIDITE
;
PSYCHOPATHOLOGIE
;
ADDICTION
;
PRISE EN CHARGE
;
PSYCHOTHERAPIE
;
PHARMACOTHERAPIE
;
FORMATION
;
SANTE MENTALE
;
PREVALENCE
;
OPIOIDES
;
STIMULANTS
;
CANNABIS
;
HYPNOTIQUES
;
INTERVENTION
;
RECOMMANDATION
Résumé :
Co-occurring mental health and substance use disorders ('dual disorders') are a key concern for policy and service planning in Europe, prompting calls for more integrated and coordinated care systems. This [...] miniguide [...] explores how European countries are responding to the challenge.
This publication is part of our wider series of miniguides on evidence-based responses to drug-related problems in Europe. It examines how mental health disorders and substance use disorders can interact, complicating diagnosis, treatment and recovery. The guide stresses that improving care for dual disorders will require closer coordination between mental health and substance use services, better data collection and sustained investment in integrated systems. It also highlights the need for more research and improved monitoring of mental health conditions among people entering drug treatment in Europe. [Editor's abstract]
This publication is part of our wider series of miniguides on evidence-based responses to drug-related problems in Europe. It examines how mental health disorders and substance use disorders can interact, complicating diagnosis, treatment and recovery. The guide stresses that improving care for dual disorders will require closer coordination between mental health and substance use services, better data collection and sustained investment in integrated systems. It also highlights the need for more research and improved monitoring of mental health conditions among people entering drug treatment in Europe. [Editor's abstract]